How CVS and other retailers will dole out any surplus Covid vaccine …

CVS COVID vaccine

How CVS and other retailers will dole out any surplus Covid vaccine …

As Covid-19 vaccination efforts get underway at major retailers and pharmacies, what to do with excess vaccine becomes a bigger question.
How CVS and other retailers will dole out any surplus Covid vaccine dosesMenuSearch quotes, news & videosMenuHow CVS and other retailers will dole out any surplus Covid vaccine dosesPublished Thu, Feb 11 20212:28 PM ESTUpdated Thu, Feb 11 20213:16 PM ESTShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailKey PointsMajor retailers and pharmacies such as CVS and Walgreens are starting their rollout of the Covid-19 vaccine.In order to avoid wasting any vaccine doses, some will use a waitlist strategy or consider vaccinating employees who qualify when there is surplus.Both versions of the vaccine need to be stored at very low temperatures. After thawing, the vaccine must be administered within hours. In addition, vaccine vials contain multiple doses.A healthcare worker wearing a protective mask fills a syringe with a dose of the Pfizer-BioNTech Covid-19 vaccine at a large scale vaccination site in Sacramento, California, Feb. 4, 2021.David Paul Morris | Bloomberg | Getty Images

As Covid-19 vaccination efforts get underway at major retailers and pharmacies such as and , what to do with excess vaccine becomes a bigger question.

Both versions of the vaccine need to be stored at very low temperatures. After thawing, the vaccine must be administered within hours. In addition, vaccine vials contain multiple doses.

Companies told that they are planning to use waitlists and will consider vaccinating employees who are eligible when excess supplies are available. The goal is to avoid wasting any doses, which continue to be in short supply.

Starting Thursday, to thousands of pharmacies and grocery stores such as and in the U.S. This move will start with about 6,500 retail locations and help accelerate the rollout, ensuring that more Americans will be protected from .

The companies are scheduling appointments based on the amount of vaccine they receive at each location, but they could find themselves with surplus vaccine if customers don't show up for an appointment or if a vaccine vial contains more vaccine than anticipated.

Currently only two vaccines, one from – and another from , have received emergency use authorization from the Food and Drug Administration. Both types require two doses of the shot to be effective.

The retailers are having to navigate varying state and local rules on eligibility requirements as they manage waitlists and determine what to do with any excess doses. In some states, retail workers qualify to receive the vaccine, while in other states they are not considered a high priority group unless they are above a certain age or have a specific medical condition.

A Walmart spokeswoman told the paper that the retailer has approached shoppers or workers who qualify under a state's guidelines with an opportunity to be vaccinated if there is surplus supply.

Walmart worked with state health departments on protocols to avoid waste, a Walmart spokesperson told CNBC. These protocols allow excess opened and available doses to be administered to individuals, including employees, who fall under eligible groups in order of priority.

A Walgreens spokesperson told CNBC that they will consider their employees for the remaining doses and will communicate with state and local jurisdictions for doses beyond that.

Meanwhile, pharmacists at CVS will keep a list of qualified patients by state and will use that to determine who receives leftover doses of the vaccine, senior vice president of CVS Health Chris Cox told CNBC.

VIDEO3:3203:32Walgreens sr. vp on plan for vaccines to go directly to pharmaciesRelated TagsNews Tips

CNBC Newsletters

|||

Join mobilsocial social network mobilsocial

Categories: United States Latest News
USA latest News | Canada latest News | Australia latest News